SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Open-market buys and sells only — the deliberate trades. Zero here doesn’t mean no filings: grants, option exercises and tax withholding (below) are compensation, not market trades.
| Insider | Role | Date | Transaction | Shares | Value |
|---|---|---|---|---|---|
| Doellinger Chad J | Chief Legal & Admin. Officer | 2026-08-13 | Open-market sell 10b5-1 | 228 | $34K |
| Giamartino Emma E. | CFO & Chief Investment Officer | 2026-08-13 | Open-market sell 10b5-1 | 2250 | $334K |
| Kohli Vikramaditya | COO & CEO, Advisory Services | 2026-07-29 | Open-market sell 10b5-1 | 2666 | $400K |
| Cobert Beth F. | Director | 2026-05-27 | Gift | 2068 | $0 |
| Cobert Beth F. | Director | 2026-05-27 | Gift | 2068 | $0 |
| GILYARD REGINALD HAROLD | Director | 2026-05-26 | Gift | 2068 | $0 |
| GILYARD REGINALD HAROLD | Director | 2026-05-26 | Gift | 2068 | $0 |
| Goodman Shira | Director | 2026-05-26 | Gift | 2068 | $0 |
| Goodman Shira | Director | 2026-05-26 | Gift | 2068 | $0 |
| Sanjiv Yajnik | Director | 2026-05-26 | Gift | 2068 | $0 |
| Sanjiv Yajnik | Director | 2026-05-26 | Gift | 2068 | $0 |
| Boze Brandon B | Director | 2026-05-21 | Grant/award | 1907 | $0 |
| Boze Brandon B | Director | 2026-05-21 | Grant/award | 839 | $110K |
| Cobert Beth F. | Director | 2026-05-21 | Grant/award | 1907 | $0 |
| GILYARD REGINALD HAROLD | Director | 2026-05-21 | Grant/award | 1907 | $0 |
| Goodman Shira | Director | 2026-05-21 | Grant/award | 1907 | $0 |
| LOPEZ GERARDO I | Director | 2026-05-21 | Grant/award | 1907 | $0 |
| Metcalfe Guy A | Director | 2026-05-21 | Grant/award | 1907 | $0 |
| Sanjiv Yajnik | Director | 2026-05-21 | Grant/award | 1907 | $0 |
| Sanjiv Yajnik | Director | 2026-05-21 | Grant/award | 1526 | $200K |
Fiscal period ending 2025-12-31 versus 2024-12-31 — view filing on EDGAR →
A 67% surge in total debt to $6.0B, combined with new federal contracting liability exposure and an escalating AI/biometric regulatory perimeter, marks a meaningful broad-based deterioration in the risk profile. The removal of an interest coverage covenant alongside rising leverage removes a key creditor protection precisely when balance-sheet risk is growing. Partial offset from the elimination of a $1.4B non-consolidated investment risk is real but insufficient to change the overall direction.
3 company-specific · 1 eased/removed · 1 common-mode
New disclosure of U.S. federal government contracting risks: uncapped liability, debarment, compliance requirements, and payment disruption from shutdowns.
The success of our BOE business depends on our ability to enter into mutually beneficial contracts, deliver high quality levels of service, manage our contractual obligations and accurately assess…
Total debt increased 67% ($3.6B to $6.0B) and interest expense rose 11% ($440M to $490M). Removal of interest coverage ratio covenant requirement also noted.
Risks Related to Our Indebtedness Our debt instruments impose operating and financial restrictions on us, and in the event of a default, all of our borrowings would become immediately due and…
Consolidated real estate equity increased 54% ($649M to $1.0B) and committed unfunded capital rose 37% ($330M to $226M net). Larger exposure increases concentration risk and potential loss magnitude.
Our REI businesses, including our real estate investment programs and co-investment activities, subject us to performance and real estate investment risks which could cause fluctuations in our…
Removal of $1.4B non-consolidated investment risk disclosure. Suggests either divestiture, consolidation, or material reduction in exposure to impairment/loss risk.
Risks Related to our Investments We have equity investments in certain companies or projects that we do not control, which subject us to risks related to their respective businesses. As of December…
New AI regulation risk disclosed (EU AI Act). Addition of India to compliance scope and Texas biometric law. Escalated regulatory landscape.
Our business is subject to complex and evolving United States and international laws and regulations regarding privacy, data protection, and cybersecurity. Many of these laws and regulations are…
CBRE issued a press release on July 29, 2026 reporting Q2 2026 financial results, including GAAP EPS of $0.69, Core EPS of $1.56, revenue of $11.2 billion (up 16%), and raised 2026 core EPS outlook to $7.80–$7.90. This is a standard quarterly earnings disclosure furnished as Exhibit 99.1 under Item 2.02, meeting the definition of earnings_release.
View raw filing on EDGAR →CBRE entered into a new $1 billion 364-day senior unsecured revolving credit facility on June 23, 2026, replacing its prior facility. The facility features SOFR-based pricing, a leverage ratio covenant, and a maturity date of June 22, 2027.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from CBRE's annual meeting held on May 21, 2026, including election of 10 directors, ratification of KPMG LLP as independent auditor, advisory approval of named executive officer compensation, and rejection of a stockholder proposal regarding special meetings. Item 5.07 is the designated Item for shareholder vote results, and the filing presents detailed vote tallies for each proposal.
View raw filing on EDGAR →